|
|
Peplin, Incorporation - Sales Analysis Snapshot
Business Description This Report provides a comprehensive Sales & Margin summary analysis for Peplin, Incorporation Tabular results include up to a ten-year history on Sales, EBITDA (Earnings before Interest, Taxes, Depreciation and Amortization), Income before Extraordinary Items and number of Employees. Additional ratios are included for sales growth, earnings and income as a percent of sales and Sales per Employee.
Peplin, Incorporation. The Group's principal activities are developing and commercializing medical dermatology products for the treatment of cancers and other diseases . Its products include PEP005 Topical gel, which is used for treating Actinic keratosis (AK) and Basal cell carcinoma (BCC), PEP005 IV for Leukemia, PEP005 IC for Superficial bladder cancer and EPUFAs for general cancer and pain. It operates in Australia.
Not the Report you are looking for? Click here for more browsing options.
Layout and Content of a Typical Report
|
|
|
|
|